to prevent strokes in those with atrial fibrillation due to non heart valve causes, and at least 1 additional
Industry application
Human Pharmaceutical
Description
Dabigatran (Pradaxa in Australia, Europe, USA and Canada (previously was Pradax in Canada, name change to Pradaxa as of January 2013),Prazaxa in Japan) is an oral anticoagulant from the class of the direct thrombin inhibitors. It is used for various clinical indications, and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner"), since it does not require frequent blood tests for international normalized ratio monitoring, while offering similar results in terms of efficacy.
Find new trading partners and manage your transactions through every step of the Pharmaceutical supply chain from Quoting to Shipping. Whether you're a buyer or a supplier the iOPharma platform will benefit your organisation.
